Drug Profile
Research programme: fumaryl acetoacetate hydrolase inhibitors - Bayer
Alternative Names: fumaryl acetoacetate hydrolase inhibitors research programme - BayerLatest Information Update: 08 Nov 2006
Price :
$50
*
At a glance
- Originator Bayer
- Class
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 08 Nov 2006 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 30 Apr 2002 Preclinical trials in Cancer in USA (unspecified route)